SCHEMBL17607367

SCHEMBL17607367

O=C(O)N1Cc2ccc(OCC3CC3)cc2C(O)C1

nearest known ligand 0.53

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ACACB O00763 17/20 0.53
ABHD6 Q9BV23 1/20 0.49
CPT2 P23786 1/20 0.44
CPT1A P50416 1/20 0.44
F10 P00742 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16624117 0.84 ACACB (0.51) ACACBABHD6
SCHEMBL17965644 0.82 ALDH1A1 (0.40) ACACBABHD6
SCHEMBL17965640 0.82 ACACB (0.42) ACACB
SCHEMBL17607339 0.82 GRIN1 (0.48)
SCHEMBL17993878 0.81 ACACB (0.53) ACACB
SCHEMBL17585135 0.80 ACACB (0.52) ACACBABHD6
SCHEMBL23774090 0.78 ACACB (0.51) ACACBABHD6
SCHEMBL16624097 0.78 ACACB (0.56) ACACB
SCHEMBL17607351 0.77 ACACB (0.52) ACACBABHD6CPT2CPT1AF10
SCHEMBL17607369 0.74 ESR2 (0.41) ABHD6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3194367-A1 TETRAHYDROISOQUINOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR THE TREATMENT OF OBESITY AND DIABETES Boehringer Ingelheim International GmbH (DE) 2017-07-26 EP disclosed
WO-2016041845-A1 TETRAHYDROISOQUINOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR THE TREATMENT OF OBESITY AND DIABETES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2016-03-24 WO disclosed